COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 122 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,560,700 | -10.1% | 562,000 | -13.5% | 0.34% | +1.2% |
| Q2 2023 | $13,968,500 | -10.4% | 650,000 | 0.0% | 0.33% | -10.8% |
| Q1 2023 | $15,593,500 | -7.3% | 650,000 | -10.3% | 0.37% | -8.1% |
| Q4 2022 | $16,820,000 | +44.8% | 725,000 | 0.0% | 0.40% | +35.0% |
| Q3 2022 | $11,615,000 | -9.6% | 725,000 | 0.0% | 0.30% | -19.8% |
| Q2 2022 | $12,847,000 | -13.0% | 725,000 | 0.0% | 0.37% | +0.5% |
| Q1 2022 | $14,761,000 | +9.0% | 725,000 | 0.0% | 0.37% | +18.8% |
| Q4 2021 | $13,543,000 | -23.8% | 725,000 | -19.4% | 0.31% | -16.3% |
| Q3 2021 | $17,766,000 | -18.3% | 900,000 | -2.2% | 0.37% | -13.0% |
| Q2 2021 | $21,749,000 | -0.3% | 920,000 | 0.0% | 0.43% | -9.7% |
| Q1 2021 | $21,804,000 | -1.0% | 920,000 | -16.4% | 0.48% | +1.9% |
| Q4 2020 | $22,033,000 | -9.9% | 1,100,000 | -6.4% | 0.47% | -24.8% |
| Q3 2020 | $24,464,000 | +19.0% | 1,175,000 | 0.0% | 0.62% | +10.1% |
| Q2 2020 | $20,563,000 | +7.2% | 1,175,000 | 0.0% | 0.56% | -28.9% |
| Q1 2020 | $19,188,000 | -40.8% | 1,175,000 | -25.4% | 0.79% | -22.6% |
| Q4 2019 | $32,414,000 | +78.9% | 1,575,000 | -0.2% | 1.02% | +41.8% |
| Q3 2019 | $18,114,000 | -12.7% | 1,577,893 | 0.0% | 0.72% | -3.9% |
| Q2 2019 | $20,749,000 | -13.1% | 1,577,893 | 0.0% | 0.75% | -18.5% |
| Q1 2019 | $23,889,000 | -13.3% | 1,577,893 | -1.7% | 0.92% | -29.2% |
| Q4 2018 | $27,560,000 | +13.3% | 1,605,105 | -2.7% | 1.30% | +47.7% |
| Q3 2018 | $24,322,000 | -38.2% | 1,650,100 | +0.0% | 0.88% | -41.8% |
| Q2 2018 | $39,353,000 | -19.8% | 1,650,000 | -14.1% | 1.51% | -27.7% |
| Q1 2018 | $49,056,000 | +40.9% | 1,920,000 | +1.8% | 2.09% | +32.6% |
| Q4 2017 | $34,811,000 | +83.9% | 1,885,729 | +4.5% | 1.58% | +80.7% |
| Q3 2017 | $18,934,000 | -15.8% | 1,805,000 | +0.4% | 0.87% | -23.1% |
| Q2 2017 | $22,495,000 | +31.5% | 1,798,195 | +5.8% | 1.14% | +15.1% |
| Q1 2017 | $17,102,000 | -31.4% | 1,700,000 | +6.2% | 0.99% | -40.8% |
| Q4 2016 | $24,912,000 | -16.3% | 1,600,000 | +3.6% | 1.67% | -10.6% |
| Q3 2016 | $29,757,000 | +106.7% | 1,545,000 | +27.2% | 1.86% | +75.0% |
| Q2 2016 | $14,398,000 | -30.7% | 1,215,000 | +6.1% | 1.07% | -38.8% |
| Q1 2016 | $20,782,000 | -24.8% | 1,145,000 | +13.9% | 1.74% | -16.9% |
| Q4 2015 | $27,651,000 | +25.8% | 1,005,487 | +1.1% | 2.10% | +17.4% |
| Q3 2015 | $21,986,000 | +63.3% | 994,400 | +31.8% | 1.78% | +81.6% |
| Q2 2015 | $13,462,000 | – | 754,600 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |